Connect to other sites within the UBM Medica Network
The risk includes a 1.99X higher risk for stroke and 1.93X higher risk of CV mortality.
5 New Things about COPD
Identifying risk, a promising mortality biomarker, and a new app for study recruitment—just a few of the latest developments in COPD research and patient care.
Antioxidant Vitamins Protect Men Against COPD
Vitamins C and E, in particular, have a beneficial effect on COPD risk and lung function in men, a new study found.
Multidisciplinary Asthma Care: It Takes a Village
Effective asthma care requires attention to comorbidities, complications, and human characteristics of each patient. Speakers at CHEST 2015 described "the village."
Clinical Evolution in Asthma and COPD
New approaches discussed at CHEST 2015 ranged from the impact of bariatric surgery on asthma control to endobronchial valve placement in COPD.
Emerging Pharmacotherapy in COPD: Update from CHEST 2015
In a well-attended session at CHEST 2015 a number of promising new therapies for treating COPD were reviewed by study authors.
Safety of COPD Medications: Current Evidence
COPD is one of the primary lung diseases seen in primary care. A CHEST 2015 panel session reinforced that treatment is often a risk/benefit balance.
Primary Care Management of Multimorbidity: COPD, for Example
Exacerbations of COPD often complicate CV outcomes. Two studies presented at CHEST 2015 looked at ways to refine risk factors for CV decline.
By clicking Accept, you agree to become a member of the UBM Medica Community.